首页> 外国专利> Probe of iodine-123 marker thymidine (FLT)analogue 123I-IaraU

Probe of iodine-123 marker thymidine (FLT)analogue 123I-IaraU

机译:碘-123标记胸苷(FLT)模拟[ 123 I] -IaraU的探针

摘要

A tumor radiation probe of iodine-123 marker thymidine (FLT) analogue [123I]-IaraU is disclosed. Commercial available uridine is used as the raw material for the synthesis of the precursor. A radioactive iodine-123 is marked on an alkaline group of uridine to obtain [123I]-IaraU, which is distinguishable from [18F]-FLT marking 18F on a glycosyl group to obtain a novel tumor radiation probe. The marking procedures include mixing the marker precursor with Na [123I] solution, acetic acid and hydrogen peroxide solution, and the solution of chloroform and sodium hydroxide. The sonication time increases from 1 minute to 10 minutes, so that [123I]-IaraU has radiologically chemical purity of higher than 98% and radiological specific activity of not less than 0.196 GBq/umole, and the yield can increase from 8% to 40%. Its radioactive specific activity, yield and purity reach to the degree for the use in biological experiments, while reducing production cost.
机译:公开了一种碘-123标记胸苷(FLT)类似物[ 123 I] -IaraU的肿瘤放射探针。使用可商购的尿苷作为合成前体的原料。在尿苷的碱性基团上标记放射性碘123,以获得[ 123 I] -IaraU,该标记与[ 18 F] -FLT标记有区别糖基上的18 F,得到一种新型的肿瘤放射探针。标记程序包括将标记前体与Na [ 123 I]溶液,乙酸和过氧化氢溶液以及氯仿和氢氧化钠溶液混合。超声处理时间从1分钟增加到10分钟,因此[ 123 I] -IaraU的放射化学纯度高于98%,放射比活度不低于0.196 GBq / umole,并且产量可以从8%增加到40%。其放射性比活度,产率和纯度达到了用于生物实验的程度,同时降低了生产成本。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号